Biosimilars to usher new growth, lead $1 trillion drug exports by 2030
Biosimilars
are poised to drive the next wave of growth in the
Indian pharmaceutical industry
and help the country achieve an ambitious goal of $1 trillion in
drug exports
by 2030, a senior industry executive told ET.
The country's biosimilars market has the potential to exceed $60 billion by 2030, according to Namit Joshi, chairman of
Pharmexcil
, an authorised export promotion agency under the commerce and industry ministry. That would be about half of the whole pharma exports, which is expected to grow to $120-130 billion by 2030 from $50-$55 billion at present.
"Large Indian pharmaceutical companies such as
Biocon
, Dr Reddy's, and
Cipla
have already begun to make considerable strides in
biologics
and biosimilars, with product launches in advanced markets like the US and Europe," Joshi said. "These firms have the financial muscle, global regulatory experience, and technological infrastructure to navigate the complexities involved in the development and approval of such products." According to him, biologics, biosimilars, digital therapeutics and other high-value,
innovation-driven
categories represent the next phase of growth beyond traditional generics, offering opportunities to move up the global value chain.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Skype Phone Alternative
www.telidesk.com
Undo
However, success in these segments requires long-term strategic planning, robust regulatory preparedness, and, most importantly, significant investment in research and development, Joshi said. The ambition export target for 2030 was set at a meeting held in the commerce ministry with Pharmexcil officials.
Live Events
Joshi said achieving this ambition of growing at 11-12% compound annual growth rate (CAGR) requires collaborative efforts from all stakeholders-pharmaceutical companies, the government, regulatory agencies, and Indian embassies/missions abroad.
"A CAGR growth of 11-12 % is definitely possible with pursuing opportunities in newer product classes such as biosimilars (especially those of off-patented molecules), gene therapy and specialty drugs," he said. It is estimated the global generic market is expected to grow at 5%, he said. India's drug exports, mainly generics, have been growing at 5-8% in recent years.
To speed up growth, it is important to ensure inclusive participation in industry's transformation to innovation-driven high-value categories and leverage India's
manufacturing capacity
, Joshi said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
17 minutes ago
- Mint
Another rate cut if inflation slows? Here's what RBI Governor Sanjay Malhotra says
The Reserve Bank of India (RBI) may plan to cut interest rates further if inflation goes below its projection or growth comes under pressure, Governor Sanjay Malhotra stated. 'The monetary policy committee will always factor in the evolving situation, the outlook, and then decide what the economy really needs,' Malhotra said during an interview with CNBC-TV18 on Tuesday. 'Certainly, the policy rates can be cut' if inflation falls below the central bank's forecast or growth stays weak, he noted. Although price stability remains the central bank's main goal, growth is also an important factor. In its June monetary policy meeting, the central bank reduced its key rate significantly to support India's slowing economy. 'One cannot say inflation is more important than growth; it's always the mix of both factors,' the RBI governor said. 'Both are equally important, and I would not say we are giving more weight to either number at this point,' he added. Sanjay Malhotra's remark comes a day after June inflation fell to the lowest in more than six years, mainly due to slowing food prices. The governor stated that the central bank will remain data-dependent moving forward, and there is an expectation that this year's inflation may fall below the 3.7 per cent forecast. Sanjay Malhotra stated that 6.5 per cent growth projection for India is "aligned with our expectations", though signals are mixed. 'The monsoon is favourable, we're seeing optimism in consumer surveys, trade deals are ongoing,' he said. Since February, the central bank has reduced the repo rate by 100 basis points, including a half-point cut and a move toward a more hawkish neutral stance in the recent policy meeting. On Tuesday, Malhotra stated that the RBI's policy framework aims to align overnight borrowing costs with the benchmark repurchase rate, which is currently at 5.5 per cent. The framework seeks to achieve this by injecting or absorbing liquidity as necessary. The RBI is reviewing its regulations regarding bank ownership, which could result in allowing foreign banks to hold larger stakes in domestic lenders. The central bank is considering whether to permit foreign banks to hold a 26 per cent ownership stake in local banks as a "general matter of policy", according to the governor. At present, foreign investors, including portfolio investors, are allowed a 74 per cent stake in Indian banks. However, regulations limit a strategic foreign investor's stake to 15 per cent. The RBI plans to review and approve an investor's request to increase their stake to 26 per cent. As the RBI simplifies the regulations, these uncertainties will be clarified, he said. When asked if the regulator would reconsider its long-standing concerns about allowing business conglomerates to own banks, the governor responded, "Conducting business and real economic activities within the same group presents a conflict of interest.' Malhotra also mentioned that an internal RBI committee has examined the current liquidity management framework and plans to publish a report with its findings by the end of this month.
Time of India
18 minutes ago
- Time of India
Bitcoin, Ether, XRP to witness 2022-like cryptocurrency company bankruptcies? Here are latest hints
Bitcoin, XRP, Ether have so far driven Cryptocurrency sector in 2025. Some of the biggest moves in financial markets were for crypto, where bitcoin continues to set records. This upcoming week is Crypto Week in Washington, where Congress will consider several bills to 'make America the crypto capital of the world'. Bitcoin retreated, having hit a record high above $123,200 Monday thanks to optimism over possible regulatory changes for crypto assets in the United States. Crypto asset markets have gradually recovered in recent years, after a series of crypto company bankruptcies in 2022 revealed widespread misconduct across the nascent industry and left millions of investors out of pocket. Will there be same scenario again? It is highly unlikely that Bitcoin and other cryptocurrencies will have the same fateful consequences as in 2022. Big Boost for Bitcoin by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Man Revealing His Strategy To Earn Upto 3K-5K Daily Income thefutureuniversity Learn More Undo Standard Chartered will allow institutional clients to trade bitcoin and ether through its UK branch, the bank said on Tuesday, becoming what it said was the first global systemically important bank to offer such crypto services. Some financial institutions have said they are seeing more client demand for crypto products as the price of bitcoin hits record highs, helped by U.S. President Donald Trump's pro-crypto stance. Live Events Institutional clients around the world, including corporates, investors and asset managers, will be able to conduct spot crypto trading through Standard Chartered's existing platforms, and will soon be offered non-deliverable forwards trading, the bank said in a statement. Over 70 Cryptocurrency Assets Standard Chartered already offers crypto products, including trading, via two independent subsidiary companies: Zodia Markets and Zodia Custody. Zodia Markets allows clients to trade more than 70 crypto assets, a spokesperson for Standard Chartered said. "As client demand accelerates further, we want to offer clients a route to transact, trade and manage digital asset risk safely and efficiently within regulatory requirements," Chief Executive Bill Winters said in the statement. Crypto Week The U.S. House of Representatives is set to pass a series of crypto-related bills this week, which the Republican majority has dubbed "crypto week". Some U.S. banks are holding internal discussions about expanding into crypto, a sector many had previously avoided, and France's Societe Generale last month became the world's first major bank to launch a dollar-pegged stablecoin. FAQs Q1. What will happen in Crypto week? A1. The U.S. House of Representatives is set to pass a series of crypto-related bills this week, which the Republican majority has dubbed "crypto week". Q2. How is Bitcoin performing? A2. Bitcoin retreated, having hit a record high above $123,200 Monday thanks to optimism over possible regulatory changes for crypto assets in the United States.
Economic Times
21 minutes ago
- Economic Times
NSE shares undervalued, says Axis Securities; pegs fair value at this price
Shares of NSE, currently valued at around Rs 2,250, appear undervalued and potentially attractive at current levels, according to estimates by Axis Securities. The stock also trades at a relatively reasonable valuation when compared to its listed peers, BSE and MCX. Tired of too many ads? Remove Ads NSE's current valuation Share price outlook Regulatory impact on NSE Tired of too many ads? Remove Ads Shares of NSE, currently valued at around Rs 2,250, appear undervalued and potentially attractive at current levels, according to estimates by Axis Securities . The stock also trades at a relatively reasonable valuation when compared to its listed peers, BSE and an earnings per share (EPS) of 49.2 and the sector trading at a price-to-earnings (P/E) multiple of 83, NSE's fair value is estimated to be around Rs 4,000, indicating significant upside from current NSE and other Indian indices are collectively at higher valuation (PE), Axis noted. "This is justified by higher growth expectations and emerging market dynamics, whereas US markets trade at lower multiples reflecting stability and scale," it share price has remained stable with steady growth and limited volatility. Axis said that the only significant dip occurred in 2023, driven by global recession fears, rate hikes, and ongoing geopolitical tensions. "Apart from this, the price trajectory has been largely unaffected," the note minor pullbacks or corrections may occur in response to shifts in market sentiment, regulatory changes or major external disruption, the overall outlook remains positive in Axis' late 2024, SEBI tightened derivatives rules, cutting NSE's F&O volumes and revenue by up to 40%.Sebi via its October 1, 2024 circular had introduced measures to strengthen the equity index derivatives framework. Among the measures introduced by Sebi were limiting the weekly expiry to just one benchmark per exchange. The market watchdog also introduced an additional margin of 2% of the contract size on all short option contracts to curtail speculative July 2025, a ban on Jane Street led to a drop in options trading, though volumes should recover, Axis More: Explained: What is Jane Street and how it made Rs 36,500 crore profit by gaming Dalal Street NSE's initial public offering is one of the most anticipated public issues. The exchange has grappled with governance issues, which has delayed its IPO despite a Rs 643 crore issue is expected by mid-2026, Axis also demands stronger cyber security and data privacy, prompting system upgrades.
